🇺🇸 FDA

Company profile · Sponsor

Aktis

Aktis Oncology

AKTS · NYSE pharma BOSTON, MA, USA
Pipeline
2
Drugs
0
Patents
1

Quick answer

Aktis (AKTS) is a pharma company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 1 patent to this profile..

Company facts

Ticker AKTS
Exchange NYSE
Company type pharma
Headquarters BOSTON, MA, USA
SEC CIK 0002035832

Pipeline (2)

Search pipeline →

  1. [225Ac]Ac-AKY-1189 (therapeutic)

    Aktis

    Urothelial Carcinoma Bladder

    phase 1 small molecule active

    1 trial

  2. [225Ac]Ac-AKY-2519 (therapeutic)

    Aktis

    Castration Resistant Metastatic Prostate Cancer

    phase 1 small molecule active

    1 trial

Patents (1)

Search patents →

  1. US 12427212

    Nectin-4 binding miniproteins, conjugates and uses thereof

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Aktis?

Aktis (AKTS) is a pharma company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 1 patent to this profile..

What pipeline programs does Aktis sponsor?

We track 2 ClinicalTrials.gov-linked programs for Aktis, including [225Ac]Ac-AKY-1189 (therapeutic) and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Aktis company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.